Dovonex and Injection site swelling - a phase IV clinical study of FDA data

Summary:

Injection site swelling is reported as a side effect among people who take Dovonex (calcipotriene), especially for people who are female, 30-39 old, also take Enbrel, and have Psoriatic arthropathy.

The phase IV clinical study analyzes which people have Injection site swelling when taking Dovonex. It is created by eHealthMe based on reports of 3,013 people who have side effects when taking Dovonex from the FDA, and is updated regularly.

What is Dovonex?

Dovonex has active ingredients of calcipotriene. It is often used in psoriasis. eHealthMe is studying from 3,035 Dovonex users. Check the latest studies of Dovonex.

What is Injection site swelling?

Injection site swelling is found to be associated with 1,061 drugs and 1,115 conditions by eHealthMe. Check the latest studies of Injection site swelling.

On Jul, 11, 2026

3,013 people reported to have side effects when taking Dovonex.
Among them, 14 people (0.46%) have Injection site swelling.

Could Dovonex cause Injection site swelling?

Among these 14 people:

What is the gender of people who have Injection site swelling when taking Dovonex? *

female: 57.14 %
male: 42.86 %

What is the age of people who have Injection site swelling when taking Dovonex? *

What are other drugs people take besides Dovonex? *

What are other side effects people have besides Injection site swelling? *

Injection Site Erythema (redness at injection site): 9 people, 64.29%
Injection Site Reaction: 7 people, 50.00%
Injection Site Pain: 5 people, 35.71%
Drug Ineffective: 4 people, 28.57%
Hypersensitivity: 3 people, 21.43%
Injection Site Warmth: 3 people, 21.43%
Injection Site Nodule (small swelling or aggregation of cells in the body, esp. an abnormal one at injection site): 2 people, 14.29%
Injection Site Pruritus (severe itching at injection site): 2 people, 14.29%
Injection Site Rash: 2 people, 14.29%
Feeling Abnormal: 2 people, 14.29%

What are the existing conditions these people have? *

Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 6 people, 42.86%
Skin Atrophy (wasting of skin): 1 person, 7.14%
Gout (uric acid crystals building up in the body): 1 person, 7.14%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Dovonex and have Injection site swelling?

- Check whether Injection site swelling is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Dovonex:

Dovonex (3,035 reports)

Browse all side effects of Dovonex:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Injection site swelling:

Injection site swelling (1,061 drugs)

Browse all the conditions that are associated with Injection site swelling:

Injection site swelling (1,115 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on calcipotriene (the active ingredients of Dovonex) and Dovonex (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.